In several tumor models, the modulation of tumor-infiltrated effector immune cells, including CD8 + , CD4 + T cells, and natural killer (NK) cells, as well as suppressor immune cells such as T regulatory cells, tumor-associated macrophages (TAMs), and myeloid-derived suppressor cells (MDSCs), can be achieved by metformin. This evidence concerns the gene CD4 and neoplasm.